Invite-only Interactive Webinar for UK/European Companies
The U.S. exit landscape is evolving rapidly. While IPOs are still the less-traveled path, they remain a sought-after outcome for premium returns.
A number of alternative approaches – including direct listings and SPACs - are making U.S. IPOs accessible to a wider array of companies. While initially appealing, the differences in outcome opportunity and underlying risks require careful consideration.
During this session, experienced IPO practitioners from Wilson Sonsini’s U.S. and UK offices will explore a range of current U.S. and cross-border IPO topics and then proceed to breakout roundtable discussions with attendees.
Topics to be discussed include:
Norilyn Ingram
ningram@wsgr.comDaniel counsels UK and European tech and life sciences companies on U.S. expansion and fundraising.
Megan represents technology and life sciences clients in corporate transactional matters.
Steve has represented non-U.S. and domestic companies in U.S. IPOs, global securities offerings, cross-border M&A, and SEC compliance for more than 25 years.
Jennifer helps innovative start-ups grow into successful enterprises by providing counsel to the founders, management teams, and boards.
Michael Labriola is a partner with Wilson Sonsini Goodrich & Rosati, where he counsels public and private technology, life sciences, and emerging growth companies through all stages of their growth. Michael has particular experience with Wilson Sonsini’s clients across the U.S. East Coast and Europe. He has a particular focus on supporting companies that undertake transformative events, such as growth financings, IPOs, acquisitions, and exit sales. Michael counsels clients in matters ranging from formation and early-stage venture financing to listings of publicly traded securities on U.S. and foreign exchanges to seasoned public offerings and private and public company acquisitions. He also has considerable experience in counseling publicly held companies on disclosure matters, SEC compliance, Nasdaq and NYSE listing matters, and other securities laws issues. In addition, Michael frequently represents investment banks, venture capital funds, and private equity firms in a broad range of investment transactions.
Allison is head of the firm’s corporate department. She represents companies, investment banks, and venture and private equity firms in corporate transactions and governance matters.